CHRISTOPHER ROBERTSON: Open Payments
NPI 1710169784 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$871 in 44 payments from 10 companies in 2025. Trend: 2023 $858 · 2024 $1,094 · 2025 $871
Food & beverage: $871
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $239 |
| ABBVIE INC. | 12 | $200 |
| Exact Sciences Corporation | 6 | $125 |
| Lilly USA, LLC | 7 | $121 |
| Tris Pharma Inc | 2 | $49 |
| PFIZER INC. | 2 | $48 |
| Novo Nordisk Inc | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: Cologuard Collection Kit, MOUNJARO, FARXIGA, VRAYLAR, BREZTRI, QULIPTA, ELIQUIS, UBRELVY.
Industry payments across FL — which companies pay providers there.
